Showing 9251-9260 of 18069 results for "".
- Unveiling the Microbiota–Inflammation Nexus in Frailty and Sarcopeniahttps://reachmd.com/news/unveiling-the-microbiotainflammation-nexus-in-frailty-and-sarcopenia/2475849/The interplay of oral–gut microbiota disturbances and systemic inflammation is emerging as a key driver of frailty and sarcopenia in older adults. Recognizing that frailty affects nearly one-third of community-dwelling seniors, geriatricians and nutritionists are reevaluating microbi
- Overcoming X Inactivation Challenges in Rett Syndromehttps://reachmd.com/news/overcoming-x-inactivation-challenges-in-rett-syndrome/2475839/For pediatric neurologists and clinical geneticists, overcoming the challenges of X inactivation has long blocked the development of disease-modifying treatments for Rett syndrome, leaving care focused on symptomatic relief rather than addressing the underlying genetic cause.
- The Silent Threat: How Persistent Pollutants Compromise Immunityhttps://reachmd.com/news/the-silent-threat-how-persistent-pollutants-compromise-immunity/2475847/Persistent environmental pollutants are silently eroding immune defenses and respiratory resilience, with recent evidence revealing critical vulnerabilities from the developing fetus to chronic lung disease patients. Immunologists and pulmonologists have long recognized the insidious
- Integrating Green Spaces and Noninvasive Diagnostics in Pediatric Neurodevelopmenthttps://reachmd.com/news/integrating-green-spaces-and-noninvasive-diagnostics-in-pediatric-neurodevelopment/2475829/Underrecognized environmental influences and the invasiveness of traditional diagnostics are conspiring to delay optimal outcomes in pediatric neurodevelopment and chronic disease management, underscored by research indicating that children exposed to green spaces from before birth through
- The Impact of Socio-Economic Factors on Psychiatric Treatment Outcomeshttps://reachmd.com/news/the-impact-of-socio-economic-factors-on-psychiatric-treatment-outcomes/2475827/Socio-economic disparities are not just background noise—they directly reshape treatment strategies and outcomes in psychiatry today. In modern clinical practice, addressing mental disorders demands more than neurobiological interventions; clinicians must navigate a complex web of so
- Innovations in Gene Therapy: Exploring New Possibilities for Vision Loss, Amidst Challengeshttps://reachmd.com/news/innovations-in-gene-therapy-exploring-new-possibilities-for-vision-loss-amidst-challenges/2475833/Gene therapy in ophthalmology is entering a transformative phase as novel, non-viral approaches promise to overcome long-standing immune hurdles and redefine vision loss treatment. Decades of reliance on viral vectors have been marred by unpredictable inflammatory responses and safet
- Nanoparticle Innovations in Cancer Therapy: Precision and Challengeshttps://reachmd.com/news/nanoparticle-innovations-in-cancer-therapy-precision-and-challenges/2475828/Precision in tumor targeting remains a critical unmet need in oncology, as systemic therapies often damage healthy tissue and fall short of eradicating malignant cells. Against this backdrop, innovations in nanoparticle-based drug delivery systems are gaining momentum.
- FDA Approves Inebilizumab and Upadacitinib: New Horizons in Autoimmune Treatmenthttps://reachmd.com/news/fda-approves-inebilizumab-and-upadacitinib-new-horizons-in-autoimmune-treatment/2475801/The FDA has approved two targeted therapies, inebilizumab and upadacitinib, providing clinicians with new options to address refractory inflammation. Managing complex autoimmune conditions has long challenged clinicians with broad immunosuppression and variable patient responses. The
- Empowering Neurologists through Genetic Insights: Targeted Therapies for Neurological Diseaseshttps://reachmd.com/news/empowering-neurologists-through-genetic-insights-targeted-therapies-for-neurological-diseases/2475792/Neurologists confront a growing dilemma: standard treatment algorithms often fall short against the backdrop of individual genetic heterogeneity and diverse biological markers in disorders like Alzheimer’s disease, multiple sclerosis and rare neurodevelopmental syndromes. Insights from
- Innovative Pain Management in Anesthesiology: Adenosine and Non-Opioid Alternativeshttps://reachmd.com/news/innovative-pain-management-in-anesthesiology-adenosine-and-non-opioid-alternatives/2475807/Despite ongoing breakthroughs in anesthesiology, achieving potent analgesia while minimizing adverse effects remains an underrecognized challenge, driving interest in adenosine and other non-opioid modalities to reshape perioperative pain control. The quest to balance effective pain